319
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Joint Modeling of Blood Pressure Measurements and Survival Time to Cardiovascular Disease Complication among Hypertension Patients Follow-up at DebreTabor Hospital, Ethiopia

& ORCID Icon
Pages 621-635 | Received 21 May 2023, Accepted 01 Sep 2023, Published online: 20 Sep 2023

References

  • Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–2128. doi:10.1016/S0140-6736(12)61728-0
  • He J, Whelton PK. Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials. Am Heart J. 1999;138(3):S211–S219. doi:10.1016/S0002-8703(99)70312-1
  • Ilyas N, Rahim K, Waqar A. HYPERTENSION: SILENT KILLER. The Pro Med J. 2015;22(02):250–255. doi:10.29309/TPMJ/2015.22.02.1392
  • Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206–1252. doi:10.1161/01.HYP.0000107251.49515.c2
  • Workie DL, Zike DT, Fenta HM. Bivariate longitudinal data analysis: a case of hypertensive patients at Felege Hiwot Referral Hospital, Bahir Dar. Ethiopia BMC Res Notes. 2017;10(1):1–7.
  • Unger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension. 2020;75(6):1334–1357. doi:10.1161/HYPERTENSIONAHA.120.15026
  • World Health Organization. Noncommunicable Diseases Country Profiles 2018. World Health Organization; 2018.
  • Wolrld Health Organization. Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020. Wolrld Health Organization; 2013.
  • Gakidou E, Afshin A, Abajobir AA, et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1345–1422.
  • van de Vijver S, Akinyi H, Oti S, et al. Status report on hypertension in Africa-Consultative review for the 6th Session of the African Union Conference of Ministers of Health on NCD’s. Pan African Med J. 2014;16(1):565.
  • Kibret KT, Mesfin YM. Prevalence of hypertension in Ethiopia: a systematic meta-analysis. Public Health Rev. 2015;36(1):1–12. doi:10.1186/s40985-015-0014-z
  • Wolrld health organization. A Global Brief on Hypertension: Silent Killer, Global Public Health Crisis: World Health Day 2013. Wolrld health organization; 2013.
  • Sahle BW, Owen AJ, Krum H, et al. Incidence of heart failure in 6083 elderly hypertensive patients: the Second Australian National Blood Pressure Study (ANBP2). Eur J Heart Fail. 2016;18(1):38–45. doi:10.1002/ejhf.427
  • Lopez A. Global Burden of Disease and Risk Factors. Washington: Oxford University Press and the World Bank; 2006.
  • Keates AK, Mocumbi AO, Ntsekhe M, et al. Cardiovascular disease in Africa: epidemiological profile and challenges. Nat Rev Cardiol. 2017;14(5):273–293. doi:10.1038/nrcardio.2017.19
  • Opie L, Seedat Y. Hypertension in Sub-Saharan Populations. Circulation. 2005;112:3562–3568.
  • Anteneh ZA, Yalew WA, Abitew DB. Prevalence and correlation of hypertension among adult population in Bahir Dar city, northwest Ethiopia: a community based cross-sectional study. Int J Gen Med. 2015;8:175. doi:10.2147/IJGM.S81513
  • Addo J, Smeeth L, Leon DA. Hypertension in sub-saharan Africa: a systematic review. Hypertension. 2007;50(6):1012–1018. doi:10.1161/HYPERTENSIONAHA.107.093336
  • Mendis S, Lindholm LH, Mancia G, et al. World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries. J Hypertens. 2007;25(8):1578–1582. doi:10.1097/HJH.0b013e3282861fd3
  • Beunckens C, Molenberghs G, Thijs H, et al. Incomplete hierarchical data. Stat Methods Med Res. 2007;16(5):457–492. doi:10.1177/0962280206075310
  • Bayray A, Meles KG, Sibhatu Y, Ciccozzi M. Magnitude and risk factors for hypertension among public servants in Tigray, Ethiopia: a cross-sectional study. PLoS One. 2018;13(10):e0204879. doi:10.1371/journal.pone.0204879
  • Kiber M, Wube M, Temesgen H, et al. Prevalence of hypertension and its associated factors among adults in Debre Markos Town, Northwest Ethiopia: community based cross-sectional study. BMC Res Notes. 2019;12(1):1–6. doi:10.1186/s13104-019-4431-9
  • Awoke A, Awoke T, Alemu S, et al. Prevalence and associated factors of hypertension among adults in Gondar, Northwest Ethiopia: a community based cross-sectional study. BMC Cardiovasc Disord. 2012;12(1):1–6. doi:10.1186/1471-2261-12-113
  • Tadege G. Survival Analysis of Time to Cardiovascular Disease Complication of Hypertensive Patients at Felege Hiwot Referral Hospital in Bahir‑Dar, Ethiopia: a Retrospective Cohort Study. J Biom Biostat. 2017;8(5). doi:10.4172/2155-6180.1000369
  • Yang L, Yu M, Gao S. Joint models for multiple longitudinal processes and time-to-event outcome. J Stat Comput Simul. 2016;86(18):3682–3700. doi:10.1080/00949655.2016.1181760
  • Ibrahim JG, Chu H, Chen LM. Basic concepts and methods for joint models of longitudinal and survival data. J Clin Oncol. 2010;28(16):2796. doi:10.1200/JCO.2009.25.0654
  • Hickey GL, Philipson P, Jorgensen A, et al. Joint modelling of time-to-event and multivariate longitudinal outcomes: recent developments and issues. BMC Med Res Methodol. 2016;16(1):1–15. doi:10.1186/s12874-016-0212-5
  • Schoenfeld DA. Sample-Size Formula for the Proportional-Hazards Regression Model. Biometrics. 1983:499–503.
  • Urrutia JD, Tampis RL, Mercado JO, Baygan AM. Survival analysis for the risk of developing heart attack. Int J Pharm Pharm Sci. 2016;8(2):6–10. doi:10.22159/ijpps.2016v8s2.15210
  • British Heart Foundation. High Blood Pressure; 2017.
  • Shahoud JS, Sanvictores T, Aeddula NR. Physiology, arterial pressure regulation. Am J Cardiol. 2019.
  • Morisky DE, Ang A, Krousel‐Wood M, et al. Predictive validity of a medication adherence measure in an outpatient setting. The J Clin Hypertens. 2008;10(5):348–354. doi:10.1111/j.1751-7176.2008.07572.x
  • Morisky D, Munter P. New medication adherence scale versus pharmacy fill rates in senior with hypertension. American J Managed Care. 2009;15(1):59–66.
  • Rizopoulos D. Joint Models for Longitudinal and Time-to-Event Data: With Applications in R. CRC press; 2012.
  • Verbeke G, Fieuws S, Molenberghs G, et al. The analysis of multivariate longitudinal data: a review. Stat Methods Med Res. 2014;23(1):42–59. doi:10.1177/0962280212445834
  • Negash Y, Kassahun W, Gurmessa A, et al. Joint modeling of longitudinal systolic and diastolic blood pressure measurements of hypertensive patients receiving treatment. Electron J Appl Stat Anal. 2016;9(2):308–325.
  • Bhansali A, Dhandania VK, Deepa M, et al. Prevalence of and risk factors for hypertension in urban and rural India: the ICMR–INDIAB study. J Hum Hypertens. 2015;29(3):204–209. doi:10.1038/jhh.2014.57
  • Jabir YN, Liga AD, Bacha RH, et al. Longitudinal Systolic and Diastolic Blood Pressure Change over Time and Associated Risk Factors in Patients with Hypertension in Southwest Ethiopia: a prospective study. Afr J Health Sci. 2021;34(1):12–25.
  • Asresahegn H, Tadesse F, Beyene E. Prevalence and associated factors of hypertension among adults in Ethiopia: a community based cross-sectional study. BMC Res Notes. 2017;10(1):1–8. doi:10.1186/s13104-017-2966-1
  • Ranasinghe P, Cooray DN, Jayawardena R, et al. The influence of family history of hypertension on disease prevalence and associated metabolic risk factors among Sri Lankan adults. BMC Pub Health. 2015;15(1):1–9. doi:10.1186/s12889-015-1927-7
  • Zhou L, Chen Y, Sun N, et al. Family history of hypertension and arterial elasticity characteristics in healthy young people. Hypertens Res. 2008;31(5):833–839. doi:10.1291/hypres.31.833
  • Rodriguez CJ, Swett K, Agarwal SK, et al. Systolic blood pressure levels among adults with hypertension and incident cardiovascular events: the atherosclerosis risk in communities study. JAMA Intern Med. 2014;174(8):1252–1261. doi:10.1001/jamainternmed.2014.2482
  • He J, Ogden LG, Bazzano LA, et al. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med. 2001;161(7):996–1002. doi:10.1001/archinte.161.7.996
  • Enyew BY, Asfaw ZG. Comparison of survival models and assessment of risk factors for survival of cardiovascular patients at Addis Ababa Cardiac Center, Ethiopia: a retrospective study. Afr Health Sci. 2021;21(3):1201–1213. doi:10.4314/ahs.v21i3.29
  • Ma Y, Cheng HY, Cheng L, et al. The effectiveness of electronic health interventions on blood pressure control, self-care behavioural outcomes and psychosocial well-being in patients with hypertension: a systematic review and meta-analysis. Int J Nurs Stud. 2019;92:27–46. doi:10.1016/j.ijnurstu.2018.11.007
  • Tam HL, Wong EML, Cheung K, et al. Effectiveness of text messaging interventions on blood pressure control among patients with hypertension: systematic review of randomized controlled trials. JMIR mHealth and uHealth. 2021;9(9):e24527. doi:10.2196/24527